Download PDF
Hamostaseologie 1981; 01(03): 87-90
DOI: 10.1055/s-0038-1656595
Originalarbeiten
Schattauer GmbH

Die Rolle der Aggregationshemmer in der Therapie und Prophylaxe des Herzinfarktes

I. Scharrer
1   Abteilung für Angiologie des Zentrums der Inneren Medizin der Johann-Wolfgang-Goethe-Universität, Frankfurt/Main
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Acheson J, Danta G, Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. Brit. med. J 1969; 1: 614-615.
    CrossrefPubMedGoogle Scholar
  • 2 The Canadian Cooperative Study Group A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New Engl. J. Med 1978; 299: 53-59.
    CrossrefPubMedGoogle Scholar
  • 3 Robertson J. T. Memphis-Studie. In: Price T. R, Nelson E. Cerebrovascular Diseases Raven Press; New York: 1979
    Google Scholar
  • 4 Fields W. S, Lemak N. A, Franko wski R. R, Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-316.
    CrossrefPubMedGoogle Scholar
  • 5 Fields W. S, Lemak N. A, Frankows-ki R. F, Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Part II: Surgical group. Stroke 1978; 9: 309-319.
    PubMedGoogle Scholar
  • 6 Reuther R, Dorndorf W. Aspirin in patients with cerebral ischemia and normal angiograms or non-surgical lesions. In: Breddin K, Dorndorf W, Loew D, Marx R. (Hrsg.): Acetylsalicylic acid in cerebral ischemia and coronary heart disease Schattauer; Stuttgart: 1977
    Google Scholar
  • 7 Worthington J. W, O’Fallon W, Fu-ster W, Whisnant J. P, Kurland L. T. Effect of Aspirin in prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. Mayo Clin. Proc 1978; 53: 581-586.
    PubMedGoogle Scholar
  • 8 Olsson J-E, Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson O, Tornberg A. Antikoagulant vs Anti-Platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke 1980; 11: 4-9.
    CrossrefPubMedGoogle Scholar
  • 9 The Persantine-Aspirin Reinfarction Study Research Group Persantine and aspirin in coronary heart disease. Circulation 1980; 62: 449-461.
    CrossrefPubMedGoogle Scholar
  • 10 Aspirin Myocardial Infarction Study Research Group A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661-669.
    CrossrefPubMedGoogle Scholar
  • 11 Barnett H. J. M. Aspirin zur Verhütung des Schlaganfalls. In: Breddin K, Loew D, Überla K, Dorndorf W, Marx R. (Hrsg.): Prophylaxe venöser, peripherer, kardialer und zerebraler Gefäßkrankheiten mit Azetylsalizylsäure Schattauer; Stuttgart: 1981
    Google Scholar
  • 12 Kurtzke J. F. Critique of the Canadian »TIA« Study. In: Price T. R, Nelson E. Cerebrovascular Diseases Raven Press; New York: 1979
    Google Scholar
  • 13 Dyken M. D. Antiplatelet aggregating agents in transient ischemic attacks and the relationship of risk factors. In: Breddin K, Loew D, Überla K, Domdorf W, Marx R. (Hrsg.): Prophylaxe venöser, peripherer, kardialer und zerebraler Gefäßkrankheiten mit Azetylsalizylsäure Schattauer; Stuttgart: 1981
    Google Scholar
  • 14 Fields W. S. Persönl. Mitteilung 1980
    Google Scholar
  • 15 Sandok B. A, Furlan A. J, Whisnant J. P, Sundt T. M. Guidelines for the manage ment of transient ischemic attacks. Mayo Clin. Proc 1978; 53: 665-674.
    PubMedGoogle Scholar